BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase
27 janv. 2021 16h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Company to provide corporate overview and progress on the rollout of the PURE EP™ System BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the...
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
27 janv. 2021 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with...
BioSig to Present at the 26th Annual International AF Symposium
15 janv. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig PURE EP System Featured in the Editorial of EP Lab Digest
14 janv. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Leading industry publication calls attention to ongoing challenges in the electrophysiology labPURE EP System is highlighted as a novel technological...
BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions
13 janv. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana
12 janv. 2021 09h32 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference
06 janv. 2021 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...
BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
18 déc. 2020 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Achieves First Commercial Sale of Three PURE EP Systems
11 déc. 2020 07h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference
10 déc. 2020 15h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 10, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...